These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 24953396)

  • 21. Diagnosis and treatment of familial hypercholesterolaemia.
    Hovingh GK; Davidson MH; Kastelein JJ; O'Connor AM
    Eur Heart J; 2013 Apr; 34(13):962-71. PubMed ID: 23416791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. My Approach to the Patient With Familial Hypercholesterolemia.
    Safarova MS; Kullo IJ
    Mayo Clin Proc; 2016 Jun; 91(6):770-86. PubMed ID: 27261867
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of evolocumab treatment on low-density lipoprotein cholesterol levels in heterozygous familial hypercholesterolemic patients withdrawing from regular apheresis.
    Kawashiri MA; Nohara A; Higashikata T; Tada H; Nakanishi C; Okada H; Konno T; Sakata K; Hayashi K; Inazu A; Mabuchi H; Yamagishi M
    Atherosclerosis; 2017 Oct; 265():225-230. PubMed ID: 28926730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Familial Hypercholesterolemia and Its Related Molecules].
    Ogura M
    Rinsho Byori; 2016 Jun; 64(6):657-666. PubMed ID: 30695320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect?
    Sahebkar A; Watts GF
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):559-67. PubMed ID: 23913122
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous familial hypercholesterolaemia: update on management.
    France M
    Paediatr Int Child Health; 2016 Nov; 36(4):243-247. PubMed ID: 27967828
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenetics in the Development of Lipid Lowering Medications: Lomitapide & Mipomersen in Clinical Practice.
    Marbach JA; Thapa J; Goldenberg E; Duffy D
    Del Med J; 2015 Aug; 87(8):238-43. PubMed ID: 26402926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Promising new therapies for the treatment of hypercholesterolemia.
    Valerio MG; Velayati A; Jain D; Aronow WS
    Expert Opin Biol Ther; 2016; 16(5):609-18. PubMed ID: 26822080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent advances in the understanding and care of familial hypercholesterolaemia: significance of the biology and therapeutic regulation of proprotein convertase subtilisin/kexin type 9.
    Page MM; Stefanutti C; Sniderman A; Watts GF
    Clin Sci (Lond); 2015 Jul; 129(1):63-79. PubMed ID: 25881720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or Higher.
    Ginsberg HN; Rader DJ; Raal FJ; Guyton JR; Baccara-Dinet MT; Lorenzato C; Pordy R; Stroes E
    Cardiovasc Drugs Ther; 2016 Oct; 30(5):473-483. PubMed ID: 27618825
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Familial hypercholesterolaemia: new treatment options.
    Ezzahti M; Sijbrands EJ; Mulder MT; Roeters van Lennep JE
    Neth J Med; 2013 Jun; 71(5):227-33. PubMed ID: 23799308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mipomersen, an apolipoprotein B synthesis inhibitor, reduces atherogenic lipoproteins in patients with severe hypercholesterolemia at high cardiovascular risk: a randomized, double-blind, placebo-controlled trial.
    Thomas GS; Cromwell WC; Ali S; Chin W; Flaim JD; Davidson M
    J Am Coll Cardiol; 2013 Dec; 62(23):2178-84. PubMed ID: 24013058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PCSK9 inhibition in the management of familial hypercholesterolemia.
    Ogura M
    J Cardiol; 2018 Jan; 71(1):1-7. PubMed ID: 28784313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current Approach to the Diagnosis and Treatment of Heterozygote and Homozygous FH Children and Adolescents.
    Cohen H; Stefanutti C;
    Curr Atheroscler Rep; 2021 May; 23(6):30. PubMed ID: 33963467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study.
    Raal FJ; Hovingh GK; Blom D; Santos RD; Harada-Shiba M; Bruckert E; Couture P; Soran H; Watts GF; Kurtz C; Honarpour N; Tang L; Kasichayanula S; Wasserman SM; Stein EA
    Lancet Diabetes Endocrinol; 2017 Apr; 5(4):280-290. PubMed ID: 28215937
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol.
    Lappegård KT; Enebakk T; Thunhaug H; Hovland A
    Atherosclerosis; 2016 Aug; 251():119-123. PubMed ID: 27318831
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel Approaches for the Treatment of Familial Hypercholesterolemia.
    Bonanni L; Cutolo A; Dalla Vestra M
    Exp Clin Endocrinol Diabetes; 2016 Nov; 124(10):583-587. PubMed ID: 27711959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?
    Sbrana F; Dal Pino B; Bigazzi F; Ripoli A; Passino C; Gabutti A; Pasanisi EM; Petersen C; Valleggi A; Todiere G; Barison A; Giannoni A; Panchetti L; Becherini F; Pianelli M; Luciani R; Sampietro T
    Eur J Prev Cardiol; 2017 Sep; 24(14):1528-1531. PubMed ID: 28555526
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mipomersen and its use in familial hypercholesterolemia.
    Parham JS; Goldberg AC
    Expert Opin Pharmacother; 2019 Feb; 20(2):127-131. PubMed ID: 30526168
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potential of mipomersen in the management of familial hypercholesterolaemia.
    Gelsinger C; Steinhagen-Thiessen E; Kassner U
    Drugs; 2012 Jul; 72(11):1445-55. PubMed ID: 22799743
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.